Want to Detect Cancer Early?

Cancers detected at early stages (Stage I–II) offer far better outcomes than late-stage diagnoses. For example, the cure rate for Stage I colorectal cancer is ~62%, but drops to just 7% at Stage IV.
Enquire Now

CancerSpot, a Cutting Edge, Robust, Early Warning Test

At Strand, we believe that early warning is key to the battle against cancer. Standard tests are either invasive and cumbersome, or involve ionizing radiation, or have poor specificity. In contrast, CancerSpot works off a simple blood draw and uses a proprietary genome sequencing and analysis process (patent pending) to identify DNA methylation signatures of cancer in the blood. CancerSpot’s signatures have been learned from Indian cohorts but have also been shown to be robust across ethnicities and measurement methods.

Key Features

High Accuracy

Achieves high accuracy, with 81% sensitivity at 97% specificity on 10 cancer types

Early Warning

Detects early cancer signals, demonstrating over 79% sensitivity (at 97% specificity) for Stage I-II cancers across ten different cancer types

Minimally Invasive

A simple blood test, that needs 20 ml of blood, and no ionizing radiation or cumbersome invasive procedures

Broad Coverage

Covers 10 of the common cancers

Robust

Detects cancer signatures consistently across ethnicities

Why is CancerSpot Important?

1/9

Indians is likely to develop
cancer in their lifetime

75-80%

of patients have advanced disease (stage 3 or 4) at the time of diagnosis

Source: ‘Quantitative estimates of preventable and treatable deaths from 36 cancers worldwide: a population-based study’, The Lancet, ‘Call for Action: Making quality cancer care more accessible and affordable in India’, EY and FICCI, Women, power and cancer, The Lancet, ‘Auditing costs of intensive care in cancer patients in India: A new area explored, Transforming India’s Approach to Cancer Care’, ORF, ‘Cancer research in India: Challenges & opportunities’, IUMR, news reports.

The Science Behind CancerSpot

Distinct signatures of DNA methylation in tumor cells compared to normal cells enable advanced machine learning algorithms to detect cancer.

How it Works

Cancer Cells Shed DNA

As cancer cells grow and die, they release their DNA into the bloodstream

DNA Methylation Patterns
DNA from cancer cells carry different methylation patterns as compared to DNA from normal cells
Advanced Sequencing and Analytics
CancerSpot uses advanced genome sequencing and data analysis to identify methylation patterns found in DNA fragments of tumor origin amongst trillions of normal fragments
AI for Robustness
CancerSpot uses cutting edge AI to ensure methylation patterns discovered from a cohort of Indian patients are robust across ethnicities
The Testing Journey With CancerSpot
CancerSpot covers colorectal, stomach, esophageal, liver, gallbladder, pancreatic, lung, breast, cervical, and ovarian cancers.  Many of these cancers do not have established screening protocols, and hence tests like CancerSpot are ground breaking. Given many of these cancers do not have a standard follow-up screening regimens, your doctor will suggest the best testing approach for you. This could include follow-up exams or repeated testing to see if the signal is getting stronger with time. To assist your doctor in these follow-up steps, CancerSpot will also provide the two most likely cancer types as inferred from your methylation profiles.
Specificity Sensitivity Cancer Type Identification
97% 79% of Stage I/II cancers Top 2 cancer types identified in 77% of control cases
CancerSpot is for those who are 50 or older, or those who are younger but at elevated risk (strong family history, long history of tobacco use, or elevated genetic risk). Talk to your healthcare provider about your cancer risk and whether this test is right for you.
Get Screened Now

Ready to take the next step? Get proactive. A simple blood draw could provide the early warning you need to stay ahead of cancer.

The process for CancerSpot is simple and easy. Here’s what to expect:

Inquiry

Initiate Your Screening Journey

Sample Collection
A simple blood draw
Turnaround Time

Receive results in 21 Days

Review
your CancerSpot score and guidance on next steps
Ask any questions
to our Genetic Counselor
*Disclaimer:
  1. CancerSpot is a screening test and is not meant for the diagnosis, cure, mitigation, treatment or prevention of any disease, including cancer.
  2. Note that CancerSpot is a screening test and cannot confirm cancer presence, i.e. the CancerSpot score is unlikely to ever be 100%.
  3. Neither can CancerSpot rule out the presence of cancer conclusively because while its sensitivity is high, it is not 100%
Explore Our Early Cancer Detection Offerring
CancerSpot

Contact Us